CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 75-95% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

LIVE MARKETS-STOXX suffers, but stays steady across the week

By Reuters News

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

STOXX SUFFERS, BUT STAYS STEADY ACROSS THE WEEK

European stocks are down across sectors and countries as Thursday's tech rout spilled across into the broader market with traders risk-averse and seeking safety elsewhere.

The STOXX 600 .STOXX is down 1%, leaving it more or less unchanged across the week. The FTSE is 1.4% lower and the DAX .GDAXI and CAC 40 .FCHI are down around 1%.

Almost European sectors are in the red, with healthcare names .SXDP down 2.2% and among the biggest decliners after biotech company Genmab's earnings disappointed somewhat. Sales of cancer drug EPKINLY slightly missed estimates, and shares were last down 5%.

Tech shares steadied, and were slightly higher on the day, after posting a 3.2% fall on Thursday, when the chip complex took a hammering. ASML ASML.AS shed 6.5% BE Semiconductor BESI.AS 7% and Soitec SOIT.PA 7%.

All were bouncing back on Friday, and Nasdaq futures are up 1%, but the broader market remained under pressure, with consumer staples, food and beverage and oil and gas stocks all down around 1.5%. .SXCSP, .SXEP, .SX3P

One single stock move to highlight is France's TP TEPRF.PA, down over 16% even after recouping some losses, after the outsourcing firm cut its full-year revenue outlook.

(Sophie Kiderlin)

EARLIER ON LIVE MARKETS:

BEFORE THE BELL: TECH WORRIES CRASH ASHORE IN EUROPE? CLICK HERE

AI'S REALITY CHECK CLICK HERE

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.